Category: Autoimmune disorders

According to Health Canada, Winpred is a corticosteroid used to treat many conditions, including allergy and inflammation. The medication, which contains the active ingredient prednisone, works by suppressing the body's immune response to relieve swelling, irritation, and redness. Understanding what is the use of Winpred is crucial for patients prescribed this potent anti-inflammatory drug.

Affecting an estimated 15,000 to 30,000 people annually in the United States, drug-induced lupus (DIL) is an autoimmune-like syndrome triggered by exposure to certain medications. While the list of potentially causative agents is extensive and constantly evolving with new treatments, definitive links exist for many common drugs. Understanding what causes drug-induced lupus is crucial for both healthcare providers and patients to facilitate early diagnosis and intervention.

An estimated 15,000–30,000 cases of drug-induced lupus occur annually in the U.S., making it a known, though rare, complication of certain medications. Understanding **what blood pressure medications trigger lupus** is vital for patients and clinicians alike, as early recognition is key for proper management.

Millions of Americans have been prescribed Ozempic (semaglutide) for type 2 diabetes and weight management since its approval. However, rare post-marketing case reports have sparked questions, leading many to ask: **Can Ozempic cause lupus?**

According to the National Institutes of Health, ustekinumab is a human monoclonal antibody belonging to the class of interleukin inhibitors. This advanced biologic medication, commonly known as Stelara, targets specific proteins in the immune system to treat a variety of inflammatory and autoimmune diseases.

Prompt treatment for giant cell arteritis (GCA) is crucial to prevent vision loss, a complication that affects up to 20% of untreated patients. This necessity makes understanding **what is the drug of choice for giant cell arteritis?** a critical question for patients and clinicians alike.

The incidence of hydralazine-induced ANCA vasculitis is dose-dependent, rising from 5.4% in patients taking 100 mg/day to 10.4% for those on 200 mg/day for over three years [1.7.2]. So, what are the symptoms of hydralazine induced vasculitis to watch for?

Doxycycline is one of the most commonly prescribed antibiotics in the US, with over 5 million prescriptions annually, yet cases suggesting a link to vasculitis are exceedingly rare. Though vasculitis can be triggered by medications, the connection between **doxycycline and vasculitis** is not well-established and primarily documented through isolated case reports, not large-scale studies.

Over 30 years of research have demonstrated that multiple sclerosis (MS) is an inflammatory, immune-mediated disease, creating a rationale for the use of immunosuppressive therapy. A wide range of immunosuppressants are used in the treatment of multiple sclerosis, from older chemotherapy agents to newer, highly-targeted monoclonal antibodies and oral drugs.

While Thyroid Eye Disease (TED) is a complication that frequently develops in individuals with Graves' disease, the drug Tepezza (teprotumumab) specifically treats the ocular condition, not the underlying systemic autoimmune disease. Understanding this crucial difference is key for patients seeking effective treatment for eye-related symptoms like bulging and double vision.